Treatment of hemophilia a and von Willebrand's disease with 1-deamino-8-D-arginine vasopressin (DDAVP) . Hemophilia and DDAVP
Ingerslev, J.; Christiansen, S.E.; Kristensen, T.; Wallevik, K.; Bernvil, S.S.
Ugeskrift for Laeger 147(45): 3592-3594
1985
ISSN/ISBN: 0041-5782 PMID: 3907076 Document Number: 249377
Document emailed within 1 workday
Related Documents
Pfueller, S.L.; Howard, M.A.; White, J.G.; Menon, C.; Berry, E.W. 1987: Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome Thrombosis and Haemostasis 58(4): 1060-1063Lumholtz, I.B. 1977: Drug information. Therapeutic main group: antidiuretics. Preparation DDAVP (deamino arginine vasopressin); Minurin, Lypressinum; Insipid retard; Vasopressin Sygeplejersken 77(30): 21
Ockelford, P.A.; Menon, N.C.; Berry, E.W. 1980: Clinical experience with arginine vasopressin (DDAVP) in von Willebrand's disease and mild haemophilia New Zealand Medical Journal 92(672): 375-378
Takase, T.; Nishino, M.; Yasui, M.; Shima, M.; Yoshikawa, N.; Fukui, H. 1985: Multimeric composition of factor VIII-related protein following DDAVP infusion in normal subjects and patients with hemophilia a and von Willebrand's disease Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 48(7): 1571-1578
Gebauer, E.; Protić, M. 1981: Use of DDAVP in the treatment of a child with hemophilia Medicinski Pregled 34(5-6): 239-241
Limal, J.M.; Mugner, E.; Czernichow, P. 1977: Treatment of ADP responsive diabetes insipidus in children with DDAVP (1-desamino-8-D-arginine-vasopressin) Archives Francaises de Pediatrie 34(10): 965-972
Derkx, F.H.; Man in 't Veld, A.J.; Jones, R.; Reid, J.L.; Schalekamp, M.A. 1983: DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin? Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 1(2): 58-61
Somerfield, S.D.; Hocken, A.G. 1977: Desamino arginine vasopressin (DDAVP) as a diagnostic agent New Zealand Medical Journal 86(600): 472-473
Lutze, G.; Schlote, A.; Beyer, H.; Kropf, S. 1985: Diagnosis of hemophilia and Willebrand-Jürgens syndrome. 2. Results of studies in hemophilia patients and hemophilia carriers Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 40(16): 479-483
Brink, H.S.; Derkx, F.H.; Boomsma, F.; Brommer, E.J.; Schalekamp, M.A. 1993: 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus Netherlands Journal of Medicine 43(1-2): 5-12
Köhler, M.; Hellstern, P.; Miyashita, C.; von Blohn, G.; Wenzel, E. 1986: Comparative study of intranasal, subcutaneous and intravenous administration of desamino-D-arginine vasopressin (DDAVP) Thrombosis and Haemostasis 55(1): 108-111
Foster, P.A. 1995: The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 74(2): 784-790
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Sultan, Y.; Loyer, F.; Venot, A. 1992: Impaired fibrinolytic response to DDAVP in patients with von Willebrand's disease Nouvelle Revue Francaise D'hematologie 34(1): 55-60
Gerards, L.J.; van Leeuwen, E.F.; Donckerwolcke, R.A.; Kuijten, R.H. 1975: Treatment of vasopressin-sensitive diabetes insipidus in children with DDAVP Nederlands Tijdschrift Voor Geneeskunde 119(33): 1269-1272
Vicente, V.; Alegre, A.; Alberca, I. 1987: Use of desmopressin in the treatment of mild forms of hemophilia a and von Willebrand's disease Medicina Clinica 88(9): 353-355
Vicente, V.; Alberca, I.; Moraleda, J.M.; López Borrasca, A. 1983: DDAVP: alternative therapy in moderate pathology of Factor VIII/von Willebrand Sangre 28(4): 531-532
Bolland, J.; Lambotte, C. 1978: Factor VIIi in hemophilia and von Willebrand's disease Revue Medicale de Liege 33(8): 284-295
Kharchenko, M.F.; Egorova, L.V.; Bitiukova, E.S.; Tutova, I.I.; Nazarova, N.S.; Papaian, L.P.; Kargin, V.D. 1998: Leukocyte and thrombocyte glycosaminoglycans in hemophilia a and von Willebrand's disease Terapevticheskii Arkhiv 70(3): 67-71
Opatrný, K.; Vít, L.; Opatrný, K.; Sefrna, F.; Cepelák, V.; Bláha, J. 1992: Results of studies of indicators of hemostasis in hemodialyzed patients during administration of 1-deamino-8-D-arginine vasopressin Casopis Lekaru Ceskych 131(11): 334-338